Meet
Kelly L. George

Kelly George supports clients in navigating the regulatory strategy and FDA policy environment for products in the space of drugs, biologics, and medical devices.

Trained as a peptide chemist, she provides in-depth technical knowledge to guide clients by translating technical information into clear strategic policy responses.

Prior to joining Avalere, Kelly focused on pipeline technologies in pre-FDA approval phases of development at the Innovation Institute. Prior to that, she worked as a scientific consultant with Fourth River Solutions where she focused on business strategy development and in-depth market analysis on medical devices.

Kelly has a PhD in peptide chemistry from the University of Pittsburgh and a BS in biology from James Madison University.

Authored Content


On August 6, Avalere’s regulatory experts published an article in BioDrugs highlighting upcoming regulatory changes for insulin.